Oasmia Pharmaceutical AB Basic And Diluted Earnings Loss Per Share
Oasmia Pharmaceutical AB reported Basic And Diluted Earnings Loss Per Share of -SEK 0.71 for the 12-month period ending 2018-04-30, per its 20-F filed 2018-09-14.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:BasicAndDilutedEarningsLossPerShare · last filed 2018-09-14
SEK
| Period end | Basic And Diluted Earnings Loss Per Share 12 month |
|---|---|
| 2018-04-30 | -0.71 SEK 20-F · filed 2018-09-14 |
| 2017-04-30 | -1.39 SEK 20-F · filed 2018-09-14 |
| 2016-04-30 | -1.36 SEK 20-F · filed 2018-09-14 |
SEK/shares
| Period end | Basic And Diluted Earnings Loss Per Share 12 month |
|---|---|
| 2018-04-30 | -0.71 SEK/shares 20-F · filed 2018-09-14 |
| 2017-04-30 | -1.39 SEK/shares 20-F · filed 2018-09-14 |
| 2016-04-30 | -1.36 SEK/shares 20-F · filed 2018-09-14 |